Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Write for us
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Video
  • Podcasts
  • New for You
  • Covid-19
  • Video
  • Podcasts

Search Results for coronavac

Brazil’s Anvisa Gets Around to Emergency Authorization After Some Confusion Involving CoronaVac Efficacy Rates

After much confusion, especially with the Sinovac vaccine results, The Brazilian National Health Surveillance Agency (Anvisa) approved the emergency use […]

Brazil’s Anvisa Gets Around to Emergency Authorization After Some Confusion Involving CoronaVac Efficacy Rates
5 days ago
Share
0

China’s Vaccine Maker Sinovac (CoronaVac) Secures $500m for Expansion

Sinovac Life Sciences Co., Ltd. (Sinovac), a subsidiary of Sinovac, has secured $500 million in funding for further development, capacity […]

China’s Vaccine Maker Sinovac (CoronaVac) Secures $500m for Expansion
2 months ago
Share
0

Phase 1 & 2 Study Reveals CoronaVac COVID-19 Vaccine Candidate Inferior to BNT162B2 & mRNA-1273

A Chinese firm, known as Sinovac, one of the leading COVID-19 vaccine developer contenders, recently revealed results from a peer-reviewed […]

Phase 1 & 2 Study Reveals CoronaVac COVID-19 Vaccine Candidate Inferior to BNT162B2 & mRNA-1273
2 months ago
Share
2

Sinovac’s CoronaVac trial reauthorized by Anvisa: Phase 3 Clinical Trial Continues on

TrialSite recently reported that the Brazilian drug regulatory authority has halted the Sinovac (CoronaVac) COVID-19 vaccine trial, however days later […]

Sinovac’s CoronaVac trial reauthorized by Anvisa Phase 3 Clinical Trial Continues on
2 months ago
Share
0

Sao Paulo State Seeking ANVISA Greenlight for CoronaVac Registration: Buys 46m at $1.95 per Dose

Sao Paulo state government in Brazil has requested from Brazil’s national health regulator, Anvisa, to register CoronaVac, the vaccine candidate developed […]

Sao Paulo State Seeking ANVISA Greenlight for CoronaVac Registration Buys 46m at $1.95 per Dose
4 months ago
Share
0

Phase 3 CoronaVac Trial in Indonesia Moves Along while BPOM Plans an Audit of Sinovac Facility in China

Thus far, Indonesian authorities report the relatively smooth running of the Phase 3 Sinovac COVID-19 clinical trial vaccine candidate. Conducted […]

Phase 3 CoronaVac Trial in Indonesia Moves Along while BPOM Plans an Audit of Sinovac Facility in China
4 months ago
Share
0

Indonesia Joins Sinovac to Initiate Phase 3 Testing of CoronaVac While Securing Option to Purchase 100m Doses

Indonesia’s Bio Farma, a state-run pharmaceutical company, plans to produce 100 million doses of COVID-19 vaccine product developed by Sinovac. In […]

Indonesia Joins Sinovac to Initiate Phase 3 Testing of CoronaVac While Securing Option to Purchase 100m Doses
6 months ago
Share
0

CoronaVac Moves to Phase 3 Clinical Trial in Brazil with Up to 9,000 to be Enrolled

Sinovac Biotech Ltd. (“Sinovac”) (Nasdaq: SVA), a Chinese biopharmaceutical company developing a COVID-19 vaccine candidate (CoronaVac), announced that its Brazilian […]

CoronaVac Moves to Phase 3 Clinical Trial in Brazil with Up to 9,000 to be Enrolled
7 months ago
Share
0

Sinovac Secures $15m Via Convertible Debt Deal to Support Race to Produce COVID-19 Vaccine ‘CoronaVac’

Sinovac Biotech Ltd (Sinovac) (NASDAQ: SVA) is a Chinese biotech company vying for a leading position in the race to develop […]

Sinovac Secures $15m Via Convertible Debt Deal to Support Race to Produce COVID-19 Vaccine ‘CoronaVac’
8 months ago
Share
0

Philippines President Takes Swipe at Pfizer to Position Chinese Vaccine: But the Data Tells a Different Story

Rodrigo Duterte, the controversial President of the Philippines, hasn’t really embraced, nor even appreciated, the past good relations between the […]

Philippines President Takes Swipe at Pfizer to Position Chinese Vaccine But the Data Tells a Different Story
4 days ago
Share
0

Posts navigation

Older posts

Trending News

  • Not Using Ivermectin, One Year In, Is Unethical And Immoral
    Not Using Ivermectin, One Year In, Is Unethical And Immoral
  • New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
    New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
  • An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
    An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
  • In Far-Flung Places, COVID-19 Is Being Treated Early And Well. Here’s Why Americans Don’t Know This.
    In Far-Flung Places, COVID-19 Is Being Treated Early And Well. Here’s Why Americans Don’t Know This.
  • Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert
    Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.